CSIMarket Company Name, Ticker, Competitors, else..


Atara Biotherapeutics Inc   (NASDAQ: ATRA)
Other Ticker:  
 

Atara Biotherapeutics Inc

ATRA's Fundamental analysis



Looking into Atara Biotherapeutics Inc growth rates, revenue grew by 928.14 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 90

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.45 %

Atara Biotherapeutics Inc net loss decreased from $-60 millions, to $-13 millions in IV. Quarter 2024,

• More on ATRA's Growth


Atara Biotherapeutics Inc
realized a net loss in trailing twelve months.

Atara Biotherapeutics Inc realized cash reduction of $ -0.11 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.17.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.02.


• More on ATRA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,699,281
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 25.32
 Tangible Book Value (Per Share $) -13.00

Atara Biotherapeutics Inc
realized net loss in trailing twelve months.

Atara Biotherapeutics Inc realized cash outflow of $ -0.11per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.17.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.02.


• More on ATRA's Valuation

•  Market Capitalization (Millions $) 45
•  Shares Outstanding (Millions) 7
•  Employees 153
•  Revenues (TTM) (Millions $) 260
•  Net Income (TTM) (Millions $) -85
•  Cash Flow (TTM) (Millions $) -1
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,699,281
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 25.32
•  Tangible Book Value (Per Share $) -13.00

•  Market Capitalization (Millions $) 45
•  Shares Outstanding (Millions) 7
•  Employees 153
•  Revenues (TTM) (Millions $) 260
•  Net Income (TTM) (Millions $) -85
•  Cash Flow (TTM) (Millions $) -1
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 0.48
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 1.95
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com